Detalles de la búsqueda
1.
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.
Lancet
; 370(9603): 1907-14, 2007 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-18068514
Resultados
1 -
1
de 1
1
Próxima >
>>